Pharmaron Beijing Co., Ltd.
300759
Ранг среди акций
#2354
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a... Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Цена акции
$5.58
Рыночная капитализация
$8.24B
Изменение (1 день)
-3.77%
Изменение (1 год)
28.36%
Страна
CN
Торговля Pharmaron Beijing Co., Ltd. (300759)
Категория
Healthcare
Выручка компании Pharmaron Beijing Co., Ltd. (300759)
Выручка на Jun 2026 TTM: $2.28B
Согласно последним финансовым отчетам Pharmaron Beijing Co., Ltd., текущая выручка компании (TTM) составляет $2.28B. В 2024 году компания получила выручку $1.68B больше, чем выручке в 2023 году, которая составила $1.63B. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Pharmaron Beijing Co., Ltd. с 2014 по 2026
Выручка на конец каждого года
| Год | Выручка | Изменить |
|---|---|---|
| 2026 (TTM) | $2.28B | 12.93% |
| 2025 | $2.01B | 19.79% |
| 2024 | $1.68B | 3.18% |
| 2023 | $1.63B | 9.52% |
| 2022 | $1.49B | 27.08% |
| 2021 | $1.17B | 49.03% |
| 2020 | $785.83M | 45.64% |
| 2019 | $539.57M | 27.62% |
| 2018 | $422.78M | 19.90% |
| 2017 | $352.61M | 49.80% |
| 2016 | $235.38M | 35.50% |
| 2015 | $173.71M | 36.12% |
| 2014 | $127.61M | 0.00% |
Выручка аналогичных компаний или конкурентов
| Компания | Выручка | Разница в выручке | Страна |
|---|---|---|---|
| $12.62B | 454.89% |
US
|
|
| $2.23B | -2.07% |
US
|
|
| $15.74B | 592.03% |
AU
|
|
| $10.11B | 344.41% |
BE
|
|
| $6.02B | 164.66% |
NL
|
